Pfizer settles New York probe into 'deceptive' copay coupons

Pfizer on Thursday settled charges by New York's attorney general that it misled consumers in its drug copayment coupon program into thinking they would pay far less to fill prescriptions than what they actually wound up paying. Pfizer agreed to pay $500,000 in fines and costs, and make more than $200,000 in restitution over the coupons.

Pfizer on Thursday settled charges by New York's attorney general that it misled consumers in its drug copayment coupon program into thinking they would pay far less to fill prescriptions than what they actually wound up paying. Pfizer agreed to pay $500,000 in fines and costs, and make more than $200,000 in restitution over the coupons. New York Attorney General Barbara Underwood said the drug manufacturer's coupons were "deceptive" because Pfizer buried limits on the total savings in the small print, and that thousands of consumers ended up paying much more. The settlement resolves claims from 2014 to 2017, and Underwood said the rate at which New York consumers paid more than the advertised maximums went up over time. Pfizer acknowledged some of the attorney general's findings but did not admit or deny liability. Reimbursements will go to consumers who used coupons in the last 3 years.